With declining renal mass, patients with CKD lose the ability to produce erythropoietin (EPO) and develop anemia due to low blood iron, inflammation, hemorrhage, EPO resistance, or relative EPO deficiency. The gene discussed is EPO; the disease is anemia (phenotype).